A phase II open-label study of aprepitant as anti-emetic prophylaxis in patients with acute myeloid leukemia (AML) undergoing induction chemotherapy
| Image |  |
|---|---|
| Description | scientific article from 'Supportive Care in Cancer' published on 19 October 2018 |
| Author/s | |
| Publication date | October 19, 2018 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |